# Expanded Access Remdesivir (RDV; GS-5734™)

> **NCT04302766** · — · NO_LONGER_AVAILABLE · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Coronavirus Disease 2019

## Interventions

- **DRUG:** Remdesivir

## Key facts

- **NCT ID:** NCT04302766
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04302766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04302766, "Expanded Access Remdesivir (RDV; GS-5734™)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04302766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*